Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pemmaraju, N.
178  Ergebnisse:
Personensuche X
?
1

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere.  6 (2022)  - p. 454-455 , 2022
Link: https://doi.org/10.1097/..
 
?
2

S127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) ..:

Yilmaz, M. ; Muftuoglu, M. ; Kantarjian, H....
HemaSphere.  6 (2022)  - p. 28-29 , 2022
Link: https://doi.org/10.1097/..
 
?
3

P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WI..:

Bazinet, A. ; Jabbour, E. ; Kantarjian, H....
HemaSphere.  6 (2022)  - p. 652-653 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P1043: OUTCOME OF PATIENTS WITH PREFIBROTIC MYELOFIBROSIS F..:

Masarova, L. ; Bose, P. ; Pemmaraju, N....
HemaSphere.  6 (2022)  - p. 933-934 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1066: OUTCOMES OF COVID-19 IN PATIENTS WITH MYELOPROLIFERA..:

Venugopal, S. ; Song, H. ; Young, C....
HemaSphere.  6 (2022)  - p. 956-957 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOP..:

Pemmaraju, N. ; Cuglievan, B. ; Lasky, J....
HemaSphere.  6 (2022)  - p. 420-421 , 2022
Link: https://doi.org/10.1097/..
 
?
7

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMG..:

Pemmaraju, N. ; Martinelli, G. ; Todisco, E....
HemaSphere.  6 (2022)  - p. 1708-1709 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBIN..:

Senapati, J. ; Ishizawa, J. ; Abbas, H. A....
HemaSphere.  6 (2022)  - p. 475-476 , 2022
Link: https://doi.org/10.1097/..
 
?
9

P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGE..:

Senapati, J. ; Jabbour, E. J. ; Short, N. J....
HemaSphere.  6 (2022)  - p. 267-268 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P703: ASSOCIATION BETWEEN BARIATRIC SURGERY AND OUTCOMES IN..:

Haddad, F. ; Kantarjian, H. ; Jabbour, E....
HemaSphere.  6 (2022)  - p. 598-599 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P497: PROGNOSTIC IMPACT OF RAS AND C-KIT MUTATIONS (SINGLE ..:

Abuasab, T. ; Senapati, J. ; Kadia, T....
HemaSphere.  6 (2022)  - p. 396-397 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PL..:

Abuasab, T. ; Alvarado, Y. ; Issa, G....
HemaSphere.  6 (2022)  - p. 394-395 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ..:

Venugopal, S. ; kantarjian, H. ; Maiti, A....
HemaSphere.  6 (2022)  - p. 679-680 , 2022
Link: https://doi.org/10.1097/..
 
?
14

P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY F..:

Venugopal, S. ; Jabbour, E. ; Pemmaraju, N....
HemaSphere.  6 (2022)  - p. 480-481 , 2022
Link: https://doi.org/10.1097/..
 
?
15

P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS:

Senapati, J. ; Verstovsek, S. ; Masarova, L....
HemaSphere.  6 (2022)  - p. 942-943 , 2022
Link: https://doi.org/10.1097/..
 
1-15